Kimia Biosciences Limited (BOM:530313)
India flag India · Delayed Price · Currency is INR
33.56
+0.08 (0.24%)
At close: Nov 17, 2026

Kimia Biosciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
1,0481,1491,1891,0491,2851,249
Other Revenue
-4.39-----
1,0441,1491,1891,0491,2851,249
Revenue Growth
-17.10%-3.40%13.39%-18.39%2.89%-5.89%
Cost of Revenue
606.9710.55722.18765.16977.05934.67
Gross Profit
437.06438.28467.03283.6308.11314.34
Selling, General & Admin
139146.01149.86167.71181.01158.49
Other Operating Expenses
119.94128.55114.68112.6156.53149.35
Operating Expenses
301.37313.7298.32313.23370.86337.25
Operating Income
135.69124.59168.71-29.63-62.75-22.91
Interest Expense
-25.82-27.17-35.33-44.46-37.41-31.01
Interest & Investment Income
0.290.290.220.370.290.31
Currency Exchange Gain (Loss)
-18.85-18.855.89-0.75-14.542.41
Other Non Operating Income (Expenses)
6.396.39-3.15-0.990.250.21
EBT Excluding Unusual Items
97.7185.25136.34-75.46-114.16-50.99
Gain (Loss) on Sale of Investments
---00.030.02
Gain (Loss) on Sale of Assets
-----0.79
Other Unusual Items
-0.65-0.65-3.62-9.75-
Pretax Income
97.0684.6136.34-71.84-123.88-50.18
Income Tax Expense
11.4810.2640.22-18.75-30.36-13.15
Net Income
85.5874.3496.12-53.09-93.52-37.03
Net Income to Common
85.5874.3496.12-53.09-93.52-37.03
Net Income Growth
4.61%-22.67%----
Shares Outstanding (Basic)
474747474747
Shares Outstanding (Diluted)
474747474747
Shares Change
-0.29%-----
EPS (Basic)
1.811.572.03-1.12-1.98-0.78
EPS (Diluted)
1.811.572.03-1.12-1.98-0.78
EPS Growth
5.02%-22.67%----

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-70.0926.8167.15130.28-95.8244.17
Free Cash Flow Per Share
-1.490.573.532.75-2.020.93
Gross Margin
41.87%38.15%39.27%27.04%23.97%25.17%
Operating Margin
13.00%10.85%14.19%-2.83%-4.88%-1.83%
Profit Margin
8.20%6.47%8.08%-5.06%-7.28%-2.96%
Free Cash Flow Margin
-6.71%2.33%14.06%12.42%-7.46%3.54%
EBITDA
171.36156.96200.852.72-30.036.05
EBITDA Margin
16.41%13.66%16.89%0.26%-2.34%0.48%
D&A For EBITDA
35.6732.3732.1432.3532.7328.96
EBIT
135.69124.59168.71-29.63-62.75-22.91
EBIT Margin
13.00%10.85%14.19%-2.83%-4.88%-1.83%
Effective Tax Rate
11.82%12.13%29.50%---
Revenue as Reported
1,0601,1651,2021,0651,2971,258
Advertising Expenses
-17.569.6212.4314.135.29